US$ 24.40
glp-1 agonist for prediabetes Receptor Agonists as Treatments Type 2 Diabetes New GLP-1 Guidelines for Type
Description
2007;56:A145

Cancer Control

A generic drug, like the liraglutide generic approved Monday, is a copy of a brand-name drug developed and made by another company

Industry public relations efforts typically focus on diverting attention from evidence-based policies
They are rarely tested in large human studies, and small short-term studies do not provide strong evidence 16
